RGNT RGNT
Company Profile ↓Company Overview
RGNT (RGNT) is a publicly traded company listed on with a market capitalization of $10.72M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Trades at an undemanding P/E of 2.3.
Carries low leverage with a debt-to-equity ratio of 0.25.
Recent Developments
- Trailing 12 Months Year-on-year growth — earnings -384.3%.
Growth & Price Performance
Compounded Profit Growth
| 5 Years: | - |
| 1 Year: | -384.27% |
Stock Price Performance
| 1 Year: | -72.40% |
| 6 Months: | -64.37% |
| 3 Months: | -15.51% |
| 1 Month: | -43.13% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- RSI (14)43.68 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Trading 78.0% below its 52-week high.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 0 | 0 | 0 | 0 |
| Cost of Revenue | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| Operating Expenses | - | 1.41M | 1.93M | -932.00K | 8.62M |
| Operating Income | - | -1.41M | -1.93M | 932.00K | -8.62M |
| EBITDA | - | -1.45M | -3.96M | 4.97M | -13.32M |
| Interest Expense | - | 0 | 173.00K | 171.00K | 324.00K |
| Pretax Income | - | -1.45M | -4.13M | 4.80M | -13.65M |
| Tax Provision | - | - | - | - | - |
| Net Income | - | -1.45M | -4.13M | 4.80M | -13.65M |
| Diluted EPS | -1.00 | -0.29 | -0.81 | 0.92 | - |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 1.72M | 360.00K | 482.00K | 7.62M |
| Current Assets | - | 1.72M | 360.00K | 482.00K | 7.62M |
| Cash & Equivalents | - | 1.24M | 345.00K | 229.00K | 7.38M |
| Inventory | - | - | - | - | - |
| Receivables | - | 26.00K | 8.00K | 73.00K | 230.00K |
| Total Liabilities | - | 43.78M | 46.27M | 41.59M | 2.87M |
| Current Liabilities | - | 2.61M | 3.14M | 6.49M | 2.87M |
| Long Term Debt | 6.08M | 6.47M | 7.41M | - | - |
| Total Debt | - | 6.47M | 7.62M | 4.95M | 1.20M |
| Total Equity | - | -42.06M | -45.91M | -41.10M | 4.74M |
| Shares Outstanding | - | 4.93M | 4.93M | 5.18M | 5.18M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Operating Cash Flow | -1.50M | -1.22M | -641.00K | -1.38M |
| Investing Cash Flow | - | - | - | - |
| Financing Cash Flow | 0 | 325.00K | 525.00K | 8.52M |
| Capital Expenditure | - | - | - | - |
| Free Cash Flow | -1.50M | -1.22M | -641.00K | -1.38M |
| Net Change in Cash | -1.50M | -895.00K | -116.00K | 7.15M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - |
| Operating Margin % | - | - | - | - | - |
| Net Margin % | - | - | - | - | - |
| ROE % | - | 3.4% | 9.0% | -11.7% | -287.7% |
| ROCE % | - | 157.7% | 69.5% | -15.5% | -181.7% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for RGNT
REGENTIS BIOMATERIALS LTD. SEC Filing (Jul 14, 2026) - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxQMEZXUGtPampxZ2ZJbXFUUTNyekZ3NFdWNnNnOGFSSTUzbnpSQ2FXNnVQblpoRVZmYkptUjJ0LWFYUFhaZ1JCVkEwZHNVZVFDSkR2RmdveUIwMFFvZS1GaTJtNDBpNURqcWZBWTNSMkZWNUhUcUExOWI5SzVLNzdnUmNkYnVpci1JNDNVSm…
RGNT Stock Erupts As GelrinC European Rollout Plans Ignite Trading - StocksToTrade
<a href="https://news.google.com/rss/articles/CBMihAFBVV95cUxPY0JfTE5wN29Ra3hZUzBsZ0RzTlZGSzI2MjEtRVlTRjhfd0w4UzExcWdiVVBjdXlCZ0paNUl6Ulp0ME5CTi0yYm00Y2t2cE5rS3NSTjlwYzFzN2FwcDRvdlhkY3FFbmdYWnNaYVV5YjBGMjFrSEVCZE5oR0l2TmVZeUxhSEo?oc=5" targ…
Why Did RGNT Stock Surge More Than 850% Today? - Stocktwits
<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxOb1BSTVlzUXQ2ZUVlZ1Atamt1Z2VaR2dxd1pfOGJnMmo0RWpLRklBNVZJTTBjYTllc2pSLXd6VE9vS3VXcGY4UWxZcG5mWTh3Q2xHdEFXU2cyU2I0bFJCNUJ4Ymk3NC1BSzF0R1ZSSC1pVVRDX0cwXzZiZ2YtdlpYVTJYVFVfU3lNdWhSa3…
Regentis Biomaterials Slips 9% After Soaring 506% On Monday — Here's Why RGNT Stock Is Trending - Benzinga
<a href="https://news.google.com/rss/articles/CBMi6wFBVV95cUxQZFlfMzZHQzlkNTVNU2F6eUppcGFSUXowa21yVm4zcDBMaENCY0laLVNNN1pTODd6SU8tSGtPVGV4MTNVa3RwQzZoSEVjMUM0bUs4VHY5dUpQdDM1NHVwTGozaUJTOGNZTXFBVERocTNHSHhqYjItU19UMmtrS0lzcG5IRUg1emd1UlFNam…
Regentis Biomaterials Ord Shs (RGNT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
<a href="https://news.google.com/rss/articles/CBMib0FVX3lxTE9oOGtIbFNtYmRKMmJfaTluZFo2d1ctZkxZWEJVamJPRVFQR2NTUEZuYWRUOEQzNGswd2pPaEpETGF6YjhQSzlIUFF4cHZUQ3E2MTRIczJsTEgyRkMyTkJSUHY2NlNYYjJ3YzNsaDZEZw?oc=5" target="_blank">Regentis Biomater…
These stocks are moving in today's after hours session - ChartMill
<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxPalhrSkN6OWRRM28wVDh0dTdlZzR6RjloQVhzTWU5MEZmNXFBY2lEVVA4ZHRjNWsxRXFxeW1NcmZ3WjdGaS1sY2ZHd3R1dUgxWWVyY1QtaVNIU29pNG4zMmNZbHBfTG13Tmw4Q3BjSzItcnpBdF9TYXlfbF9IN3E1UThGU1RHbms3LXhneW…
RGNT — Frequently Asked Questions
What is the current share price of RGNT?
As of 2026-08-05 17:25 PDT, RGNT trades at $2.07 on NASDAQ/NYSE. Its 52-week range is $1.28 to $9.40.
What is the market capitalisation of RGNT?
RGNT has a market capitalisation of $10.72M on NASDAQ/NYSE.
What is the P/E ratio of RGNT?
RGNT trades at a trailing price-to-earnings (P/E) ratio of 2.26. Its price-to-book (P/B) ratio is 2.26.
Is RGNT a good stock to buy?
This page provides a data-driven analysis of RGNT, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.